Medrobotics raises $20M to pursue FDA approval, EU marketing

Medrobotics, a surgical products company focused on medical robotics, raised $20 million in equity financing. The funds will be used to help extend the Medrobotics consumer market in Europe, where it has received CE marks for surgical tools, the Flex System and the Flex Retractor. The Flex System is designed for otolaryngology departments to perform minimally invasive head and neck surgeries. The startup is also gearing up for an expected FDA clearance which would allow it to market its products in the U.S. Release

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.